Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines
Accurate preoperative staging and restaging of mediastinal lymph nodes in patients with...
Announcements
[Journal of Thoracic Disease] Join us at the ERS International Congress 2018, PARIS France, 15-19 September!
Join us at the ERS International Congress 2018, PARIS France, 15-19 September!...
More
Journals More
Journal of Thoracic Disease
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 1.804 for the year 2017. JTD...
Journal of Gastrointestinal Oncology
Journal of Gastrointestinal Oncology (Print ISSN 2078-6891; Online ISSN 2219-679X; J Gastrointest Oncol; JGO), the official journal of Society for Gastrointestinal Oncology (SGO), is an open-access, international peer-reviewed journal. It is published quarterly (Sep. 2010- Dec. 2013), bimonthly (Feb. 2014 -) and openly distributed worldwide. JGO publishes manuscripts that focus on updated...
Translational Cancer Research
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel...
Translational Lung Cancer Research
Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013....
Gastrointestinal Stromal Tumor
Gastrointestinal Stromal Tumor (Gastrointest Stromal Tumor, GIST) is an international, peer-reviewed and open-access journal which focuses on gastrointestinal stromal tumor research. GIST aims to provide up-to-date and practical information on gastrointestinal stromal tumor and the specific areas of interest include, but not limited to, basic research, epidemiology, imaging, biology, drug...
Featured Articles
Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
In many cancers, including non-small cell lung cancer (NSCLC), tumor angiogenesis...
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it
The last few decades have witnessed a silent revolution in the war against NSCLC,...
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies
Targeted therapies and immunotherapies have quickly become fixtures in the treatment...
Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements
The echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase...
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are current...
The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention
Over a hundred years after the first description of this disease, lung cancer...
Lung cancer molecular epidemiology in China: recent trends
Lung cancer is both the most common diagnosed cancer and the leading cause of cancer...
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is a devastating disease with poor prognosis....
Non-small cell lung cancer: current treatment and future advances
Lung cancer has a poor prognosis; over half of people diagnosed with lung cancer die...